Final-Program-ATS-2023-AP.vp

SUNDAY • MAY 21

67

P409 Persistent Hypereosinophilia: An Unveil Case of Chronic Lymphocytic Leukemia/ R.E. Vazquez Nieves, San Juan, PR P410 Relationship Between Lung Hyperinflation and Prognosis in Patients With Chronic Obstructive Pulmonary Disease: Analysis From Prospective Kocoss Cohort/ Y. Kim, Seoul, Korea, Republic of P411 Changes of Usual Practice According to Annual Adequacy Evaluation in Patients With Chronic Obstructive Pulmonary Disease (COPD) From Nationwide Population-based Cohort Study/ Y. Kim, Seoul, Korea, Republic of P412 Cat Score Changes and the Outcomes of Chronic Obstructive Pulmonary Disease/ Y. Kim, Seoul, Korea, Republic of P413 Mortality and Hospital Outcomes in Patients for Asthma and COPD Exacerbations in Thailand During 2017-2021; a Population-based Study/ N. Nakwan, Songkhla, Thailand P414 The Life-sustaining Treatment Decision of Patients With Terminal Stage of Chronic Pulmonary Disease in Tertiary Care Hospital/ H. Lee, Busan, Korea, Republic of P415 Prospective Evaluation of Pneumonia Incidence in COPD Patients With or Without Esophageal Hiatus Hernia and GERD/ Y. Iwata, Tokyo, Japan P416 Patients With History of Non-alcoholic Fatty Liver Disease Admitted for COPD Exacerbation Have Higher Mortality and Worse Outcomes/ A. Aboelnasr, Cincinnati, OH P417 Long-term Stability of SGRQ Total Score in Individuals With AATD-associated Lung Disease Participating in Alphanet’s Disease Management Program/ R. Choate, Lexington, KY P418 Characteristics Associated With SGRQ in Alpha-1 Antitrypsin Deficiency-associated Lung Disease: A Cross-sectional Analysis/ R. Choate, Lexington, KY P419 PiSS Alpha-1 Antitrypsin Deficiency: A Clinical Risk Variant?/ D. Fraughen, Dublin, Ireland P420 Alpha-1-antitrypsin Genotyping in Underserved Patients at Risk for Alpha-1-antitrypsin Deficiency in Chicago, Illinois/ Z. Elfessi, Chicago, IL P421 Family Screening in Severe Alpha-1 Antitrypsin Deficiency - Too Little, Too Late? An Argument for Newborn Screening/ S. Roche, Dublin, Ireland P422 Is Genetic Discrimination a Problem in AATD? An Irish Perspective/ S. Roche, Dublin, Ireland P423 Machine-learning Model Identifies Patients With High Probability of Alpha-1 Antitrypsin Deficiency Across the United States/ J. Hinson, Lexington, MA

P397 Obstructive Fibrinous Tracheal Pseudomembrane Managed By Flexible Bronchoscopy With Cryoprobe/ M.M. Kimble, Plantation, FL P398 An Aberrant Tree-cheal Branch: A Case Of Tracheal Bronchus/ B. Amir-Kabirian, Charleston, WV P399 Mediastinal Mass: Recurrent Pulmonary Infections Caused By Tracheal Bronchus/ C. Yurosko, Cleveland, OH P400 Tracheal Bronchus: Lobar Collapse Revealing Swine Anatomy/ F. Chesta, Honolulu, HI

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

A41

EMERGING CLINICAL AND TRANSLATIONAL RESEARCH IN COPD AND ALPHA-1-ANTITRYPSIN

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area D, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P402 Using Multi-omics Factor Analysis to Determine the Major Axes of Heterogeneity in Chronic Obstructive Pulmonary Disease/ A. Halu, Boston, MA P403 Associations Between a Bilirubin-associated Single Nucleotide Polymorphism (SNP) and Respiratory Health Outcomes: A Mendelian Randomization Study Within COPDGene/ D.M. Macdonald, Minneapolis, MN P404 Associations Between Biomarkers of Inflammation and Longitudinal Measures of Lung Function and Physical Activity: A Secondary Analysis in CASCADE/ D.M. Macdonald, Minneapolis, MN P405 Accuracy and Reproducibility of Plethysmographic Thoracic Gas Volume Measurements in Healthy Subjects/ T. Siddharthan, Miami, FL P406 Small Airways Deposition of Two Fixed-dose Triple Therapy Combinations Assessed With Functional Respiratory Imaging (FRI)/ J. Marshall, Cambridge, United Kingdom P407 COPD Phenotypes: Pulmonary Artery:Aorta Ratio and Its Correlation to Pulmonary Vascular Resistance in Emphysema Vs. Non-emphysema COPD/ J.D. Rivera Robles, Weston, FL P408 COPD Phenotypes: Pulmonary Vascular Resistance/FEV1 Ratio, Normalizing Hemodynamics to Degree of Airflow Obstruction/ J.D. Rivera Robles, Weston, FL

ATS 2023 • Washington, DC